As of Friday noon (20 Nov), the Ministry of Health (MOH) has confirmed four new cases of COVID-19 infection.

This brings the total number of infection cases to 58,143.

There are no new cases of locally transmitted COVID-19 infection.

All of the four new cases are imported cases, who had already been placed on Stay-Home Notice upon arrival in Singapore.

Amongst the new cases today, 3 are asymptomatic and were detected from screening and surveillance, while 1 was symptomatic.

Amongst the 4 imported cases, 1 (Case 58348) is a Singaporean who returned from Sweden. Another 2 (Cases 58349 and 58350) are Work Permit holders currently employed in Singapore who arrived from Indonesia. The remaining case (Case 58347) is a Short-Term Visit Pass holder enrolled in a private school in Singapore who arrived from Russia.

MOH stated that it has been monitoring existing clusters for any further transmission. As there have been no more cases linked to the cluster at Blue Stars Dormitory (3 Kian Teck Lane) for the past two incubation periods (i.e. 28 days), the cluster has now been closed.

There are no new cases linked to existing or new clusters today.

Update on condition of confirmed cases

6 more cases of COVID-19 infection have been discharged from hospitals or community isolation facilities. In all, 58,058 have fully recovered from the infection and have been discharged from hospitals or community care facilities.

There are currently 26 confirmed cases who are still in the hospital. Of these, most are stable or improving, and 1 is in critical condition in the intensive care unit. 31 are isolated and cared for at community facilities. These are those who have mild symptoms or are clinically well but still test positive for COVID-19.

28 have passed away from complications due to COVID-19 infection.

Notify of
Inline Feedbacks
View all comments
You May Also Like

S’pore imposes ‘stricter measures’ for safe distancing amid COVID-19 outbreak, heading closer to the Red DORSCON level measures

After several local COVID-19 cases reportedly had no links to previous cases…

MOH maintains the question of whether to support expensive treatments for rare diseases when efficacy is uncertain

SINGAPORE — “There remains the broader question as to whether the Government…